ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Infectious Agents and Disease
This article is part of the Research TopicInnovative Antibiofilm Strategies: Advancing the Management of Microbial Biofilm InfectionsView all 9 articles
Staphylococcus epidermidis DnaK alters biofilm formation and proteome in Staphylococcus aureus CIP 107093
Provisionally accepted- 1Université de Rouen, Mont-Saint-Aignan, France
- 2Institut Pasteur, Paris, France
- 3Centre de Biologie Structurale, Montpellier, France
- 4NanoTemper Technologies GmbH, Munich, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Staphylococcus aureus and Staphylococcus epidermidis, two Gram-positive bacteria of the human skin microbiota, form biofilms that contribute to dysbiosis and inflammatory skin diseases such as psoriasis and atopic dermatitis. The human Calcitonin Gene-Related Peptide (CGRP), involved in skin inflammation, was previously shown to enhance the virulence of S. epidermidis MFP04. We previously observed a significant increase in the level of the molecular chaperone DnaK/Hsp70 in the secretome of CGRP-activated S. epidermidis. Here, we investigated the role of recombinant S. epidermidis DnaK in biofilm formation in S. aureus and S. epidermidis. DnaK modulates biofilm formation in a strain-dependent manner. In commensal strains (S. aureus MFP03 and S. epidermidis MFP04), it is associated with an increase in biofilm biomass. In contrast, it significantly reduces biofilm formation in the clinical S. aureus strain CIP 107093. Point mutations in the Substrate-Binding Domain (SBD) and Nucleotide-Binding Domain (NBD) of DnaK differentially affect its modulation of biofilm formation. Specifically, only the mutation in the SBD abolishes the biofilm reduction observed in CIP 107093, while the NBD mutation results in a milder effect. Notably, these mutations have no significant impact on DnaK-induced biofilm changes in strains where DnaK promotes biofilm formation. Proteomic analyses of S. aureus CIP 107093 reveal that DnaK alters the S. aureus biofilm proteome, stabilizing protein degradation components and downregulating key biofilm regulators. These findings highlight the cross-species regulatory potential of S. epidermidis extracellular DnaK in the skin microbiota.
Keywords: DnaK, Biofilm, Staphylococcus epidermidis, Staphylococcus aureus, Skin microbiota
Received: 14 Sep 2025; Accepted: 11 Dec 2025.
Copyright: © 2025 Kayser, Druart, Bouscasse, Matondo, Chane, Hoh, GROBOILLOT, Barbey, Merieau, LATOUR, Soule, Mühle, Norris and Konto-Ghiorghi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yoan Konto-Ghiorghi
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
